Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 22,799 $ 8,408
Restricted cash 250
Marketable debt securities, available for sale 3,678 8,779
Marketable equity securities, at fair value 76
Accounts receivable, net 37,832 37,708
Inventory, net 4,912 4,600
Prepaid expenses and other current assets 1,105 1,496
Total current assets 70,326 61,317
Property, plant and equipment, net 6,063 5,947
Prepaid expenses, net of current portion 121 460
Operating lease right-of-use asset, net 4,148 4,402
Intangible assets, net 8,889 10,852
Goodwill 5,709 5,709
Deferred tax asset 1,339
Other assets 1,282 608
TOTAL ASSETS 97,877 89,295
Current liabilities    
Accounts payable 1,545 7,026
Accrued diagnostic services 274 1,890
Accrued advertising and other allowances 79 104
Operating lease liabilities 301 663
Deferred revenue 2,958 2,034
Income tax payable 8,341 1,312
Other current liabilities 3,195 2,495
Total current liabilities 16,693 15,524
Non-current liabilities:    
Deferred revenue, net of current portion 927 905
Note payable 44
Unsecured convertible promissory notes, net 7,999 9,996
Operating lease liabilities, net of current portion 4,337 4,198
Total non-current liabilities 13,263 15,143
Total liabilities 29,956 30,667
COMMITMENTS AND CONTINGENCIES  
Stockholders’ equity    
Preferred stock authorized 1,000,000, $0.0005 par value, no shares issued and outstanding
Common stock authorized 50,000,000, $0.0005 par value, 16,026,164 and 15,485,900 shares outstanding, respectively 17 16
Additional paid-in capital 108,131 104,552
Retained earnings 14,198 2,642
Treasury stock, at cost, 17,711,582 and 16,818,846 shares, respectively (54,138) (48,407)
Accumulated other comprehensive loss (287) (175)
Total stockholders’ equity 67,921 58,628
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 97,877 $ 89,295